Advertisement
Original communication| Volume 92, ISSUE 1, P93-100, July 1982

Download started.

Ok

Histologic and hemodynamic effects of prostacyclin and prostaglandin E1 following oleic acid infusion

      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      The hemodynamic and histologic effects of exogenous prostacyclin (PGI2) and prostaglandin E1 (PGE1) on oleic acid-induced acute respiratory failure were investigated. Adult mongrel dogs infused with oleic acid were treated with saline solution, PGE1, and PGI2. Significantly lowered blood pressure, systemic and pulmonary vascular resistance, and arteriovenous oxygen difference and preservation of preoleic cardiac output were observed in the PGI2 group. Compared with the saline group, only the arteriovenous oxygen difference was improved with PGE1. Light microscopy revealed acute edema and inflammation in the saline- and PGE1-treated lungs. Histologic specimens in the PGI2 group were normal.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Armstrong JM
        • Chapple D
        • Dusting GJ
        • Hughes R
        • Moncada S
        • Vane JR
        Cardiovascular action of prostacyclin (PGI2) in chloralose anesthetized dogs.
        Br J Pharmacol. 1977; 61: 136P
        • Ashbaugh DG
        • Uzawa T
        Respiratory and hemodynamic changes after injection of free fatty acids.
        J Surg Res. 1967; 8: 417-423
        • Boone R
        • Rush Jr, BF
        A device for measuring oxygen consumption in the dog.
        J Surg Res. 1967; 7: 418-420
        • Bunting S
        • Gryglewski R
        • Moncada S
        • Vane JR
        Arterial walls generate from prostaglandins endoperoxidases a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation.
        Prostaglandins. 1976; 12: 897-913
        • Dusting GJ
        • Moncada S
        • Vane JR
        Recirculation of prostacyclin in the dog.
        Br J Pharmacol. 1978; 64: 315-320
        • Ellis EF
        • Shen JC
        • Schrey MP
        • Carchman RA
        • Rubin RP
        Prostacyclin: A potent stimulation of adrenal steroidogenesis.
        Prostaglandins. 1978; 16: 483-490
        • Emmons PR
        • Hampton JR
        • Harrison MJG
        • Honour AJ
        • Mitchell JRA
        Effect of prostaglandin E1 on platelet behavior in vitro and in vivo.
        Br Med J. 1967; 2: 468-472
        • Ford-Hutchinson AW
        • Wallen JR
        • Davidson EM
        • Smith MJH
        PGI2—A potential mediator of inflammation.
        Prostaglandins. 1978; 16: 253-258
        • Gryglewski RJ
        • Dembinska-Kiec A
        • Grodzinska L
        • Panczenko B
        Differential generation of substances with prostaglandinlike and thromboxane-like activities by guinea pig trachea and lung strips.
        in: Lung cells in disease. Proceedings of a Brook Lodge Conference, Augusta, Mich., April 21–23, 1976. Elsevier/North-Holland Biomedical Press, Amsterdam1976: 289-307
        • Gryglewski RJ
        • Korbut R
        • Oretkiewicz A
        Generations of prostacyclin by lungs in vivo and its release into the arterial circulation.
        Nature. 1978; 273: 764-767
        • Gryglewski RJ
        • Szczeklik A
        • Nizankowski R
        Anti-platelet action of intravenous infusion of prostacyclin in man.
        Thromb Res. 1978; 13: 153-163
        • Hammerschmidt DE
        • Harris PD
        • Wayland JH
        • Craddock PR
        • Jacob HS
        Complement-induced granulocyte aggregation in vivo.
        Am J Pathol. 1981; 102: 146-150
        • Hammerschmidt DE
        • Weaver LJ
        • Hudson LD
        • Craddock PR
        • Jacob HS
        Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome.
        Lancet. 1980; 1: 947-949
        • Jalle BM
        • Behrman HR
        • Parker CW
        Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.
        J Clin Invest. 1973; 52: 398-405
        • Johnson RA
        • Morton DR
        • Kinner JH
        • Gorman RR
        • McGuire JC
        • Sun FF
        The chemical structure of prostaglandin X (prostacyclin).
        Prostaglandins. 1976; 12: 915-929
        • Kadowitz PJ
        • Chapnick BM
        • Feigen LP
        • Human AL
        • Nelson PK
        • Spannhake EW
        Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin PGI2.
        J Appl Physiol. 1978; 45: 408-413
        • Kazui T
        • Webb WR
        • Wax SD
        Effect of prostaglandin E1 on the lung in hemorrhagic shock.
        in: Surg Forum. 27. 1976: 187-189
        • Machiedo GW
        • Brown CS
        • Lavigne JK
        • Rush Jr, BF
        Prostaglandin E1 as a therapeutic agent in hemorrhagic shock.
        in: Surg Forum. 24. 1973: 12-14
        • Machiedo GW
        • Casey KF
        • Novak RT
        • Slotman GJ
        Effect of prostaglandin inhibition of hemodynamic changes secondary to PEEP.
        Crit Care Med. 1979; 7: 141
        • Maclouf J
        • Andrieu JM
        • Dray F
        Validity of PGE1 radioimmunoassay by using PGE1 antisera with differential binding parameters.
        in: Fed Proc. 56. 1975: 273-278
        • Mathe AA
        Prostaglandins and the lung.
        in: Ramwell PW The prostaglandins. Plenum Press, New York1977: 169-224
        • Moncada S
        • Korbut R
        • Bunting S
        • Vane JR
        Prostacyclin in a circulating hormone.
        Nature. 1978; 273: 767-768
        • Moncada S
        • Gryglewski R
        • Bunting S
        • Vane JR
        An enzyme isolated from arteries transforms prostaglandins and endoperoxides to an unstable substance that inhibits platelet aggregation.
        Nature. 1976; 263: 663-665
        • Moncada S
        • Vane JR
        The role of prostacyclin in vascular tissue.
        in: Fed Proc. 38. 1979: 66-71
        • Nakano J
        • Pranean AV
        Relationship between the structure of prostaglandins and their vasoactivity in dogs.
        Pharmacologist. 1971; 13: 292
        • O'Grady J
        • Warrington S
        • Moti MJ
        Effects of intravenous infusion of prostacyclin (PG12) in man.
        Prostaglandins. 1980; 19: 319-327
        • Priano LC
        • Miller TH
        • Trober SL
        Use of prostaglandin E1 in the treatment of experimental hypovolemic shock.
        Circ Shock. 1974; 1: 221-230
        • Said SI
        • Yoshida T
        • Kitamura S
        • Vreim C
        Pulmonary alveolar hypoxia: Release or prostaglandins and other humoral mediators.
        Science. 1974; 185: 1181-1183
        • Shaw JO
        • Moser KM
        The current status of prostaglandins and the lungs.
        Chest. 1975; 68: 75-80
        • Sibbald WJ
        • Short A
        • Cohen MP
        • Wilson RF
        Variations in adrenocortical responsiveness during severe bacterial infections.
        Ann Surg. 1977; 186: 29-33
        • Slotman GJ
        • Machiedo GW
        • Casey KF
        • Novak RT
        • Rush Jr, BF
        The hemodynamic effects of prostaglandin E1 (PGE1) in acute hypoxic respiratory failure.
        in: Advances in shock research. vol 3. Alan R Liss, Inc, New York1980: 283-289
        • Smith ME
        • Gunther R
        • Gee M
        • Flynn J
        • Demling RH
        Leukocytes, platelets, and thromboxane A2 in endotoxin-induced lung injury.
        Surgery. 1981; 90: 102-107
        • Swan JH
        • Ganz W
        • Forrester J
        • Marcus H
        • Diamond G
        • Chonette D
        Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter.
        N Engl J Med. 1970; 283: 447-451
        • Szczeklik A
        • Gryglewski RJ
        • Nizankowski R
        • Musial J
        • Pieton R
        • Murk J
        Circulatory and antiplatelet effects of intravenous prostacyclin in healthy men.
        Pharmacol Res Commun. 1978; 10: 545-556
        • Tucker A
        • Weir EK
        • Reeves JR
        • Grover RF
        Pulmonary microembolism: Attenuated pulmonary vasoconstriction with prostaglandin inhibitors and antihistamines.
        Prostaglandins. 1976; 11: 31-41
        • Weir EK
        • Reeves JR
        • Grover RF
        Inhibition of prostaglandin synthetase prevents blockade of hypoxic pulmonary hypertension hy endotoxin.
        Clin Res. 1974; 22: 654A